Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Selective Cancer Therapeutics|January 1, 1990
Phase I trial and biochemical evaluation of tiazofurin administered on a weekly scheduleT J Melink, G Sarosy, A R Hanauske, et al.
The New England Journal of Medicine|December 7, 1978
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapyR C Young, B A Chabner, S P Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomasW H Wilson, B A Chabner, G Bryant, et al.
Cancer Treatment Reports|May 1, 1979
Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputationS A Rosenburg, B A Chabner, R C Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trialsJ A O'Shaughnessy, R E Wittes, G Burke, et al.
Leukemia|March 1, 1993
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group studyL Elias, D Stock-Novack, D R Head, et al.
Cancer Treatment Reports|December 1, 1986
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group StudyR B Livingston, S Schulman, J G Mira, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemiaM R Grever, K J Kopecky, C A Coltman, et al.
The New England Journal of Medicine|October 15, 1987
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndromeC J Allegra, B A Chabner, C U Tuazon, et al.
Blood|July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesI W Flinn, J C Byrd, C Morrison, et al.
Pageof 21